Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis

Cancer Letters

Volumn 289, Issue 1, 2010, Pages 11-22

  Martin Kleiner, Irena ^a   Gall Troselj, Koraljka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Cancer; IGF2; Loss of heterozygosity; M6P IGF2R; Mutation

Indexed keywords

MANNOSE 6 PHOSPHATE; METHIONINE; SOMATOMEDIN B RECEPTOR;

AMINO ACID SEQUENCE; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC POLYMORPHISM; HUMAN; LIGAND BINDING; LIVER CELL CARCINOMA; LUNG CARCINOMA; MICROSATELLITE INSTABILITY; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 75949130596     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.06.036     Document Type: Review

References (99)

1. Costello M., Baxter R.C., and Scott C.D. Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 84 (1999) 611-617
2. Killian J.K., and Jirtle R.L. Genomic structure of the human M6P/IGF2 receptor. Mamm. Genome 10 (1999) 74-77
3. Oshima A., Nolan C.M., Kyle J.W., Grubb J.H., and Sly W.S. The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells. J. Biol. Chem. 263 (1988) 2553-2562
4. Morgan D.O., Edman J.C., Standring D.N., Fried V.A., Smith M.C., Roth R.A., and Rutter W.J. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329 (1987) 301-307
5. Hawkes C., and Kar S. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res. Rev. 44 (2004) 117-140
6. Kornfeld S., and Mellman I. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5 (1988) 483-525
7. Blanchard F., Duplomb L., Raher S., Vusio P., Hoflack B., Jacques Y., and Godard A. Mannose-6-phosphate/insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J. Biol. Chem. 274 (1999) 24685-24693
8. Lee S.J., and Nathans D. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J. Biol. Chem. 263 (1988) 3521-3527
9. Mathieu M., Rochefort H., Barenton B., Prebois C., and Vignon F. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol. Endocrinol. 4 (1990) 1327-1335
10. Dennis P.A., and Rifkin D.B. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88 (1991) 580-584
11. Laureys G., Barton D.E., Ullrich A., and Francke U. Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse. Genomics 3 (1988) 224-229
12. Nykjaer A., Christensen E.I., Vorum H., Hager H., Petersen C.M., Roigaard H., Min H.Y., Vilhardt F., Moller L.B., Kornfeld S., and Gliemann J. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell Biol. 141 (1998) 815-828
13. Kang J.X., Li Y., and Leaf A. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc. Natl. Acad. Sci. USA 94 (1997) 13671-13676
14. Lemansky P., Fester I., Smolenova E., Uhlander C., and Hasilik A. The cation-independent mannose 6-phosphate receptor is involved in lysosomal delivery of serglycin. J. Leukoc. Biol. 81 (2007) 1149-1158
15. Wood R.J., and Hulett M.D. Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation. J. Biol. Chem. 283 (2008) 4165-4176
16. Di Bacco A., and Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene 22 (2003) 5436-5445
17. Lau M.M., Stewart C.E., Liu Z., Bhatt H., Rotwein P., and Stewart C.L. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8 (1994) 2953-2963
18. Wang Z.Q., Fung M.R., Barlow D.P., and Wagner E.F. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372 (1994) 464-467
19. Ludwig T., Eggenschwiler J., Fisher P., D'Ercole A.J., Davenport M.L., and Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177 (1996) 517-535
20. Wise T.L., and Pravtcheva D.D. Delayed onset of IGF2-induced mammary tumors in IGF2R mice. Cancer Res. 66 (2006) 1327-1336
21. O'Gorman D.B., Costello M., Weiss J., Firth S.M., and Scott C.D. Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res. 59 (1999) 5692-5694
22. Souza R.F., Wang S., Thakar M., Smolinski K.N., Yin J., Zhou T.T., Kong D., Abraham J.M., Toretsky J.A., and Meltzer S.J. Expression of the wild type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18 (1999) 4063-4068
23. Z.H. Chen, Y.L. Ge, N. Landman, J.X. Kang, Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells, BMC Cancer 2 (2002) (art. no. 18).
24. Li J., and Sahagian G.G. Demonstration of tumor suppression by mannose 6-phosphate/insulin-like growth factor 2 receptor. Oncogene 23 (2004) 9359-9368
25. Probst O.C., Puxbaum V., Svoboda B., Leksa V., Stockinger H., Mikula M., Mikulits W., and Mach L. The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells. Int. J. Cancer 124 (2009) 2559-2567
26. Schaffer B.S., Lin M.F., Byrd J.C., Park J.H., and MacDonald R.G. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells. Endocrinology 144 (2003) 955-966
27. Dutrillaux B., Gerbault-Seureau M., and Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet. Cytogenet. 49 (1990) 203-217
28. Lee J.H., Kavanagh J.J., Wildrick D.M., Wharton J.T., and Blick M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 50 (1990) 2724-2728
29. Saito S., Saito H., Koi S., Sagae S., Kudo R., Saito J., Noda K., and Nakamura Y. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res. 52 (1992) 5815-5817
30. Millikin D., Meese E., Vogelstein B., Witkowski C., and Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51 (1991) 5449-5453
31. Gaidano G., Hauptschein R.S., Parsa N.Z., Offit K., Rao P.H., Lenoir G., Knowles D.M., Chaganti R.S., and Dalla-Favera R. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80 (1992) 1781-1787
32. Morita R., Saito S., Ishikawa J., Ogawa O., Yoshida O., Yamakawa K., and Nakamura Y. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 51 (1991) 5817-5820
33. Hankins G.R., de Souza A.T., Bentley R.C., Patel M.R., Marks J.R., Iglehart J.D., and Jirtle R.L. M6P/IGF2 receptor - a candidate breast tumor suppressor gene. Oncogene 12 (1996) 2003-2009
34. Chappell S.A., Walsh T., Walker R.A., and Shaw J.A. Loss of heterozygosity at the mannose-6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinoma. Br. J. Cancer 76 (1997) 1558-1561
35. Berthe M.L., Esslimani Sahla M., Rogers P., Gleizes M., Lemamy G.J., Brouillet J.P., and Rochefort H. Mannose-6-phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. Eur. J. Cancer 39 (2003) 635-642
36. Iwamoto K.S., and Barber C.L. Radiation-induced posttranscriptional control of M6P/IGF2R expression in breast cancer cell lines. Mol. Carcinogen. 46 (2007) 497-502
37. de Souza A.T., Hankins G.R., Washington M.K., Fine R.L., Orton T.C., and Jirtle R.L. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 10 (1995) 1725-1729
38. Wada I., Kanada H., Nomura K., Kato Y., Machinami R., and Kitagawa T. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan. Hepatology 29 (1999) 1718-1721
39. Oka Y., Waterland R.A., Killian J.K., Nolan C.M., Jang H.S., Tohara K., Sakaguchi S., Yao T., Iwashita A., Yata Y., Takahara T., Sato S.I., Suzuki K., Masuda T., and Jirtle R.L. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology 35 (2002) 1153-1163
40. Sue S.R., Chari R.S., Kong F.M., Mills J.J., Fine R.L., Jirtle R.L., and Meyers W.C. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg. 222 (1995) 171-178
41. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., and Jirtle R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11 (1995) 447-449
42. Jang H.S., Kang K.M., Choi B.O., Chai G.Y., Hong S.C., Ha W.S., and Jirtle R.L. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World J. Gastroenterol. 14 (2008) 1394-1398
43. Yamada T., Desouza A.T., Finkelstein S., and Jirtle R.L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA 94 (1997) 10351-10355
44. Piao Z., Choi Y., Park C., Lee W.J., Park J.H., and Kim H. Deletion of the M6P/IGF2R gene in primary hepatocellular carcinoma. Cancer Lett. 120 (1997) 39-43
45. Hu C.K., McCall S., Madden J., Huang H., Clough R., Jirtle R.L., and Anscher M.S. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. Prostate Cancer Prostatic Dis. 9 (2006) 62-67
46. Kong F.M., Anscher M.S., Washington M.K., Killian J.K., and Jirtle R.L. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 19 (2000) 1572-1578
47. F.O. Desmet, D. Hamroun, M. Lalande, G. Collod-Béroud, M. Claustres, C. Béroud, Human splicing finder: an online bioinformatics tool to predict splicing signals, Nucl. Acids Res., doi:10.1093/nar/gkp215.
48. Gemma A., Hosoya Y., Uematsu K., Seike M., Kurimoto F., Yoshimura A., Shibuya M., and Kudoh S. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-β1). Lung Cancer 30 (2000) 91-98
49. Grbeša I., Marinković M., Ivkić M., Krušlin B., Novak-Kujundžić R., Pegan B., Bogdanović O., Bedeković V., and Gall-Trošelj K. Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma. J. Mol. Med. 86 (2008) 1057-1066
50. Leboulleux S., Gaston V., Boulle N., Le Bouc Y., and Gicquel C. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis. Eur. J. Endocrinol. 144 (2001) 163-168
51. Rey J.M., Theillet C., Brouillet J.P., and Rochefort H. Stable amino-acid sequence of the mannose-6-phosphate/insulin-like growth-factor II receptor in ovarian carcinomas with loss of heterozygosity and in breast cancer cell lines. Int. J. Cancer 85 (2000) 466-473
52. T.A. Jamieson, D.M. Brizel, J.K. Killian, Y. Oka, H.-S. Jang, X.L. Fu, R.W. Clough, R.T. Vollmer, M.S. Anscher, R.L. Jirtle, M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis, BMC Cancer 3 (2003) (art. no. 4).
53. Pavelić J., Radaković B., and Pavelić K. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose-6-phosphate) in endometrial carcinoma. Gynecol. Oncol. 105 (2007) 727-735
54. Huang Z., Wen Y., Shandilya R., Marks R.J., Berchuck A., and Murphy S.K. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucl. Acids Res. 34 (2006) 555-563
55. de Souza A.T., Yamada T., Mills J.J., and Jirtle R.L. Imprinted genes in liver carcinogenesis. FASEB J. 11 (1997) 60-67
56. Woerner S.M., Benner A., Sutter C., Schiller M., Yuan Y.P., Keller G., Bork P., Doeberitz M.K., and Gebert J.F. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative real common target genes. Oncogene 22 (2003) 2226-2235
57. Perucho M. Tumors with microsatellite instability: many mutations, targets and paradoxes. Oncogene 22 (2003) 2223-2225
58. Seitz S., Wassmuth P., Plaschke J., Schackert H.K., Karsten U., Santibanez-Koref M.F., Schlag P.M., and Scherneck S. Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Gene Chromosome Cancer 37 (2003) 29-35
59. Souza R.F., Apel R., Yin J., Wang S., Smolinski K.N., Abraham J.M., Zou T.-T., Shi Y.-Q., Lei J., Cotrell J., Cymes K., Biden K., Simms L., Leggett B., Lynch P.M., Frazier M., Powell S.M., Harpaz N., Sugimura H., Young J., and Meltzer S.J. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat. Genet. 14 (1996) 255-257
60. Ouyang H., Shiwaku H.O., Hagiwara H., Miura K., Abe T., Kato Y., Ohtani H., Shiiba K., Souza R.F., Meltzer S.J., and Horii A. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach and colorectum. Cancer Res. 57 (1997) 1851-1854
61. Calin G.A., Gafa R., Tibiletti M.G., Herlea V., Becheanu G., Cavazzini L., Barbanti-Brodano G., Nenci I., Negrini M., and Lanza G. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGF beta RII, Bax, HMSH3, HMSH6, IGHIIR and BLM Genes. Int. J. Cancer 89 (2000) 230-235
62. Sammalkorpi H., Alhopuro P., Lehtonen R., Tuimala J., Mecklin J.P., Järvinen H.J., Jiricny J., Karhu A., and Aaltonen L.A. Background mutation frequency in microsatellite-unstable colorectal cancer. Cancer Res. 67 (2007) 5691-5698
63. Vilkki S., Launonen V., Karhu A., Sistonen P., Västrik I., and Aaltonen L.A. Screening for microsatellite instability target genes in colorectal cancers. J. Med. Genet. 39 (2002) 785-789
64. Sun X., Shen C., Vessela R.L., and Dong J.-T. Microsatellite instability and mismatch repair target gene mutation in cell lines and xenografts of prostate cancer. Prostate 66 (2006) 660-666
65. Kotsinas A., Evangelou K., Sideridou M., Kotzamanis G., Constantinides C., Zavras A.I., Douglass C.W., Papavassiliou A.G., and Gorgoulis V.G. The 3′ UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Cancer Lett. 259 (2008) 177-185
66. Zavras A.I., Pitiphat W., Wu T., Cartsos V., Lam A., Douglass C.W., and Diehl S.R. Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res. 63 (2003) 296-297
67. Betel D., Wilson M., Gabow A., Marks D.S., and Sander C.S.A. The microRNA.org resource: targets and expression. Nucl. Acids Res. 36 (2008) D149-D153
68. Savage S.A., Woodson K., Walk E., Modi W., Liao J., Douglass C., Hoover R.N., and Chanock S.J. Analysis of genes critical for growth regulation identifies insulin-like growth factor 2 receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol. Biomar. Prev. 16 (2007) 1667-1674
69. Rezgui D., Williams C., Savage S.A., Prince S.N., Zaccheo O.J., Jones E.Y., Crump M.P., and Hassan A.B. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth. J. Mol. Endocrinol. 42 (2009) 341-356
70. Killian J.K., Nolan C.M., Wylie A.A., Li T., Vu T.H., Hoffman A.R., and Jirtle R.L. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum. Mol. Genet. 10 (2001) 1721-1728
71. Xu Y.Q., Goodyer C.G., Deal C., and Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 197 (1993) 747-754
72. Barlow D.P., Stoger R., Herrmann B.G., Saito K., and Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349 (1991) 84-87
73. Oudejans C.B., Westerman B., Wouters D., Gooyer S., Leegwater P.A., van Wijk I.J., and Sleutels F. Allelic IGF2R repression does not correlate with expression of antisense RNA in human extraembryonic tissues. Genomics 73 (2001) 331-337
74. Reinhart B., Eljanne M., and Chaillet J.R. Shared role for differentially methylated domains of imprinted genes. Mol. Cell. Biol. 22 (2002) 2089-2098
75. Sandovici I., Leppert M., Red Hawk P., Suarez A., Linares Y., and Sapienza C. Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum. Mol. Genet. 12 (2003) 1569-1578
76. Vu T.H., Li T., and Hoffman A.R. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum. Mol. Genet. 13 (2004) 2233-2245
77. York S.J., Arneson L.S., Gregory W.T., Dahms N.M., and Kornfeld S. The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding. J. Biol. Chem. 274 (1999) 1164-1171
78. Byrd J.C., Park J.H., Schaffer B.S., Garmroudi F., and MacDonald R.G. Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor. J. Biol. Chem. 275 (2000) 18647-18656
79. Kreiling J.L., Byrd J.C., and MacDonald R.G. Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor. J. Biol. Chem. 280 (2005) 21067-21077
80. Hartman M.A., Kreiling J.L., Byrd J.C., and MacDonald R.G. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor. FEBS J. 276 (2009) 1915-1929
81. Linnell J., Groeger G., and Hassan A.B. Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/mannose 6-phosphate receptor: the effects of domain 13 and pH. J. Biol. Chem. 276 (2001) 23986-23991
82. Brown J., Delaine C., Zaccheo O.J., Siebold C., Gilbert R.J., van Boxel G., Denley A., Wallace J.C., Hassan A.B., Forbes B.E., and Jones E.Y. Structure and functional analysis of the IGFII/IGF2R interaction. EMBO J. 27 (2008) 265-276
83. Brown J., Esnouf R.M., Jones M.A., Linnell J., Harlos K., Hassan A.B., and Jones E.Y. Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur. EMBO J. 21 (2002) 1054-1062
84. Zaccheo O.J., Prince S.N., Miller D.M., Williams C., Kemp C.F., Brown J., Jones E.Y., Catto L.E., Crump M.P., and Hassan A.B. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues. J. Mol. Biol. 359 (2006) 403-421
85. Hancock M.K., Yammani R.D., and Dahms N.M. Localization of the carbohydrate recognition sites of the insulin-like growth factor II/mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region. J. Biol. Chem. 277 (2002) 47205-47212
86. Reddy S.T., Chai W.G., Childs R.A., Page J.D., Feizi T., and Dahms N.M. Identification of a low affinity mannose 6-phosphate-binding site in domain 5 of the cation-independent mannose 6-phosphate receptor. J. Biol. Chem. 279 (2004) 38658-38667
87. Hancock M.K., Haskins D.J., Sun G.J., and Dahms N.M. Identification of residues essential for carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate receptor. J. Biol. Chem. 277 (2002) 11255-11264
88. Dahms N.M., Rose P.A., Molkentin J.D., Zhang Y., and Brzycki M.A. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. The role of arginine residues in mannose 6-phosphate binding. J. Biol. Chem. 268 (1993) 5457-5463
89. Olson L.J., Yammani R.D., Dahms N.M., and Kim J.J. Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor. EMBO J. 23 (2004) 2019-2028
90. Devi G.R., De Souza A.T., Byrd J.C., Jirtle R.L., and MacDonald R.G. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res. 59 (1999) 4314-4319
91. Byrd J.C., Devi G.R., De Souza A.T., Jirtle R.L., and MacDonald R.G. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J. Biol. Chem. 274 (1999) 24408-24416
92. Braulke T., Tippmer S., Chao H.J., and von Figura K. Regulation of mannose 6-phosphate/insulin-like growth factor II receptor distribution by activators and inhibitors of protein kinase C. Eur. J. Biochem. 189 (1990) 609-616
93. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
94. Murayama Y., Okamoto T., Ogata E., Asano T., Iiri T., Katada T., Ui M., Grubb J.H., Sly W.S., and Nishimoto I. Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate. J. Biol. Chem. 265 (1990) 17456-17462
95. Scott C.D., and Weiss J. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. J. Cell. Physiol. 182 (2000) 62-68
96. Lee J.S., Weiss J., Martin J.L., and Scott C.D. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Int. J. Cancer 107 (2003) 564-570
97. El-Shewy H.M., Lee M.H., Obeid L.M., Jaffa A.A., and Luttrell L.M. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J. Biol. Chem. 282 (2007) 26150-26157
98. Oates A.J., Schumaker L.M., Jenkins S.B., Pearce A.A., Dacosta S.A., Arun B., and Ellis M.J.C. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) a putative breast tumor suppressor gene. Breast Cancer Res. Treat. 47 (1998) 269-281
99. Gary-Bobo M., Nirdé P., Jeanjean A., Morère A., and Garcia M. Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr. Med. Chem. 14 (2007) 2945-2953